Article ; Online: Applications of Immunomagnetic Reduction Technology as a Biosensor in Therapeutic Evaluation of Chinese Herbal Medicine in Tauopathy Alleviation of an AD
2022 Volume 12, Issue 10
Abstract: Alzheimer's disease (AD) is the most common form of dementia. The most convincing biomarkers in the blood for AD are currently β-amyloid (Aβ) and Tau protein because amyloid plaques and neurofibrillary tangles are pathological hallmarks in the brains of ... ...
Abstract | Alzheimer's disease (AD) is the most common form of dementia. The most convincing biomarkers in the blood for AD are currently β-amyloid (Aβ) and Tau protein because amyloid plaques and neurofibrillary tangles are pathological hallmarks in the brains of patients with AD. The development of assay technologies in diagnosing early-stage AD is very important. The study of human AD subjects is hindered by ethical and technical limitations. Thus, many studies have therefore turned to AD animal models, such as |
---|---|
MeSH term(s) | Animals ; Humans ; tau Proteins ; Alzheimer Disease/drug therapy ; Alzheimer Disease/pathology ; Drosophila/metabolism ; Drugs, Chinese Herbal/therapeutic use ; Drosophila melanogaster/metabolism ; Tauopathies/drug therapy ; Amyloid beta-Peptides ; Biosensing Techniques ; Technology |
Chemical Substances | tau Proteins ; Drugs, Chinese Herbal ; Amyloid beta-Peptides |
Language | English |
Publishing date | 2022-10-17 |
Publishing country | Switzerland |
Document type | Journal Article |
ZDB-ID | 2662125-3 |
ISSN | 2079-6374 ; 2079-6374 |
ISSN (online) | 2079-6374 |
ISSN | 2079-6374 |
DOI | 10.3390/bios12100883 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.